Article Versions Notes

Gronnier C, Mariette C, Lepage C, Monterymard C, Jary M, Ferru A, Baconnier M, Adhoute X, Tavan D, Perrier H, et al. Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study. Cancers. 2023; 15(7):2188. https://doi.org/10.3390/cancers15072188

Gronnier, Caroline, Christophe Mariette, Come Lepage, Carole Monterymard, Marine Jary, Aurélie Ferru, Mathieu Baconnier, Xavier Adhoute, David Tavan, Hervé Perrier, and et al. 2023. "Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study" Cancers 15, no. 7: 2188. https://doi.org/10.3390/cancers15072188

Gronnier, C., Mariette, C., Lepage, C., Monterymard, C., Jary, M., Ferru, A., Baconnier, M., Adhoute, X., Tavan, D., Perrier, H., Guerin-Meyer, V., Lecaille, C., Bonichon-Lamichhane, N., Pillon, D., Cojocarasu, O., Egreteau, J., D’journo, X. B., Dahan, L., Locher, C., ... Piessen, G. (2023). Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study. Cancers, 15(7), 2188. https://doi.org/10.3390/cancers15072188